Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Keppra 500mg/5ml concentrate for solution for infusion vials
0408010A0BBAFAJ
|
Keppra | Levetiracetam | Central Nervous System | 52 |
|
Midazolam 2.5mg/0.25ml oromucosal soln pf oral syringes SF
0408020V0AAAXAX
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 52 |
|
PecFent 100micrograms/dose nasal spray
0407020A0BPAABJ
|
PecFent | Fentanyl | Central Nervous System | 52 |
|
Ropiqual XL 2mg tablets
0409010H0BKAAAK
|
Ropiqual | Ropinirole hydrochloride | Central Nervous System | 52 |
|
Xenazine 25 tablets
0409030C0BCAAAA
|
Xenazine | Tetrabenazine | Central Nervous System | 52 |
|
Aprepitant 80mg capsules
0406000ADAAAAAA
|
Aprepitant | Aprepitant | Central Nervous System | 50 |
|
Chloral hydrate 200mg/5ml oral suspension
0401010B0AABGBG
|
Chloral hydrate | Chloral hydrate | Central Nervous System | 50 |
|
Gabapentin 100mg/5ml oral solution
0408010G0AABIBI
|
Gabapentin | Gabapentin | Central Nervous System | 50 |
|
OxyContin 120mg modified-release tablets
0407020ADBCAFAP
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 50 |
|
ReQuip 5mg tablets
0409010H0BBADAD
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 50 |
|
Buspirone 7.5mg tablets
0401020B0AAADAD
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 49 |
|
Diazepam 2.5mg/1.25ml rectal solution tube
0401020K0AABQBQ
|
Diazepam | Diazepam | Central Nervous System | 49 |
|
Dosulepin 25mg/5ml oral solution
0403010J0AABJBJ
|
Dosulepin hydrochloride | Dosulepin hydrochloride | Central Nervous System | 49 |
|
Ebixa tablets treatment initiation pack
0411000G0BBADAE
|
Ebixa | Memantine hydrochloride | Central Nervous System | 49 |
|
Nortriptyline 25mg/5ml oral solution sugar free
0403010V0AAAVAV
|
Nortriptyline | Nortriptyline | Central Nervous System | 49 |
|
Perphenazine 2mg tablets
0402010Q0AAACAC
|
Perphenazine | Perphenazine | Central Nervous System | 49 |
|
Inovelon 40mg/ml oral suspension
0408010AFBBADAD
|
Inovelon | Rufinamide | Central Nervous System | 48 |
|
Latuda 37mg tablets
0402010AIBBABAB
|
Latuda | Lurasidone | Central Nervous System | 48 |
|
Tephine 400microgram sublingual tablets
0407020B0BFABAD
|
Tephine | Buprenorphine | Central Nervous System | 48 |
|
Abtard 10mg modified-release tablets
0407020ADBMABAF
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 47 |
|
Atogepant 10mg tablets
0407042U0AAAAAA
|
Atogepant | Atogepant | Central Nervous System | 47 |
|
Hyoscine hydrobromide 500micrograms/5ml oral suspension
0406000L0AABQBQ
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | 47 |
|
Paliperidone 263mg/1.315ml prolonged-release inj pf syringes
0402020ABAAAGAG
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 47 |
|
Fentanyl 100micrograms/dose nasal spray
0407020A0AABJBJ
|
Fentanyl | Fentanyl | Central Nervous System | 46 |
|
Invodol SR 200mg tablets
040702040BTACAE
|
Invodol SR | Tramadol hydrochloride | Central Nervous System | 46 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.